Technicals
MovingAverage
Candlestick
PivotPoint
Fundamentals
Fin Statements
Beta&Vols
Tech Charts
Future/OptionStock Analysis of Cipla Ltd. (CIPLA) - Birds Eye View
Overview
| Code | CIPLA |
| Close | 1510.50 |
| Change | -2.80 / 0.185 % |
| Volume | 1061.43 K |
| Vol Change | -57049.00 / 5.10 % |
| Industry | Drugs & Pharma |
| Sector | Healthcare |
| Type - F&O | F&O Stock List |
TSR Strength Index
| Technical Strength | Mild Bullish |
| Growth Index | Low Growth Stock |
| Value Index | Very Low Value Stock |
| Profitability Index | No Significant Profitability |
| Stability Index | Excellent Stability |
Fundamental View of Cipla Ltd.
PE (TTM)
23.13
Not GoodPrice / Book
4.30
Very PoorPrice / Sales
4.43
Very PoorPiotroski F Score
6.0
GoodMarket Cap
122010 (Cr)
Enterprise Value
121725 (Cr)
ROA (TTM)
15.32
Very GoodROE (TTM)
18.65
GoodNet Margin (TTM)
19.14
GoodRevenue
5.32 %
271454 MNet Profit
27.93 %
52725.20 MDebt to Equity
0.0097
ExcellentAltman Z Score
13.77
ExcellentQuick Ratio
3.22
Very GoodCash Ratio
1.48
IndecisiveHighs/Lows of Cipla Ltd.
| Period | Old price | Stock Return | Nifty 50 | High | Low | High Date | Low Date |
|---|---|---|---|---|---|---|---|
| One Week | 1505.90 | 0.305 % | 0.219 % | 1525.00 | 1493.30 | 02-Jul-25 | 02-Jul-25 |
| Two Week | 1499.10 | 0.760 % | 1.96 % | 1525.00 | 1492.00 | 02-Jul-25 | 27-Jun-25 |
| One Month | 1504.20 | 0.419 % | 1.83 % | 1541.00 | 1480.00 | 16-Jun-25 | 13-Jun-25 |
| Three Month | 1384.70 | 9.09 % | 14.89 % | 1570.80 | 1382.65 | 30-Apr-25 | 08-Apr-25 |
| Six Months | 1497.45 | 0.871 % | 7.40 % | 1570.80 | 1335.00 | 30-Apr-25 | 07-Apr-25 |
| One year | 1509.90 | 0.0397 % | 4.68 % | 1702.05 | 1335.00 | 09-Oct-24 | 07-Apr-25 |
| Two year | 1020.65 | 47.99 % | 31.71 % | 1702.05 | 1013.00 | 09-Oct-24 | 10-Jul-23 |
| Five year | 636.55 | 137.29 % | 135.76 % | 1702.05 | 631.25 | 09-Oct-24 | 14-Jul-20 |
| Ten year | 646.50 | 133.64 % | 199.16 % | 1702.05 | 355.30 | 09-Oct-24 | 13-Mar-20 |
Technical View of Cipla Ltd.
RSI
53.15
NeutralMACD
4.04
Mild BullishADX
11.69
BullishSuper Trend
1450.57
Mild BullishWilliams %R
-32.37
NeutralCCI
54.64
NeutralEMA 5
1509.27
BullishEMA 15
1505.84
Mild BullishEMA 50
1497.94
Mild BullishEMA 100
1493.46
Mild BullishSMA 100
1485.60
BullishSMA 200
1501.94
WhipsawSMA 5 / 20
1509.16 / 1506.61
BullishSMA 15 / 50
1504.31 / 1500.72
Mild BullishSMA 50 / 200
1500.72 / 1501.94
Mild BearishCharts of Cipla Ltd.
Returns of Cipla Ltd. with Peers
| Period / Stock | CIPLA | DIVISLAB | MAXHEALTH | TORNTPHARM |
| 1 Week | 0.305% | 1.16% | 1.85% | -1.64% |
| 1 Mth | 0.419% | 5.26% | 11.25% | 6.28% |
| 3 Mth | 9.09% | 30.99% | 20.84% | 3.67% |
| 6mth | 0.871% | 16.60% | 8.45% | -1.52% |
| 1 Year | 0.0397% | 48.79% | 42.22% | 15.95% |
| 2 Year | 47.99% | 87.77% | 113.08% | 76.23% |
| 5 Years | 137.29% | 215.34% | - | 187.36% |
| charts | - |
Compare Fundamentals of Cipla Ltd. with Peers
| Ratio / Stock | CIPLA | DIVISLAB | MAXHEALTH | TORNTPHARM |
| PE | 23.13 | 83.36 | 117.39 | 59.38 |
| P/B | 4.30 | 13.13 | 14.42 | 15.63 |
| ROA | 15.32 | 13.86 | 8.22 | 12.69 |
| ROE | 18.65 | 15.75 | 12.28 | 26.31 |
| Debt To Equity | 0.0097 | 0 | 0.321 | 0.403 |
| Revenue | 271454 M 5.32 % | 93600.00 M 19.31 % | 70284.60 M 30.01 % | 115160 M 7.35 % |
| Net Income | 52725.20 M 27.93 % | 21910.00 M 36.94 % | 10758.80 M 1.72 % | 19110.00 M 15.40 % |
Technicals of Cipla Ltd. with Peers
| Technical / Stock | CIPLA | DIVISLAB | MAXHEALTH | TORNTPHARM | - |
| ADX | 11.69 | 26.76 | 27.22 | 23.95 | |
| CMF | -0.0089 | 0.170 | 0.134 | 0.175 | |
| MFI | 58.51 | 75.94 | 80.61 | 75.64 | |
| RSI | 53.15 | 66.85 | 66.88 | 59.89 | |
| MACD Abv Signal | True | True | True | True | |
| Price Above 50 MA | True | True | True | True | - |
| Price Above 200 MA | True | True | True | True | - |
About : Cipla Limited
Address : Cipla House, Mumbai, India, 400013
Tel : 91 22 2482 6000
URL : https://www.cipla.com
Code : CIPLA, ISIN : INE059A01026, Exchange : NSE, Country : India
Fiscal Year End : March
Employee Count : 30313
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.